IPCA Laboratories reports 67% rise in Q1 net profit

IPCA Laboratories has reported results for first quarter ended June 30, 2013.

The company has reported 66.98% rise in its net profit at Rs 71.77 crore for the quarter as compared to Rs 42.98 crore for the same quarter in the previous year. Total income from operation of the company has increased by 26.34% at Rs 805.56 crore for quarter under review as compared to Rs 637.61 crore for the quarter ended June 30, 2012.

IPCA Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.